SC
DVAX

SummitTX Capital’s Dynavax Technologies DVAX Stock Holding History

SummitTX Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-216,927
Closed -$2.81M – 811
2025
Q1 		$2.81M Buy
+216,927
New +$2.87M 0.12% 194

Other funds holding DVAX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

SummitTX Capital's DVAX Position: Q2 2025 in Review

SummitTX Capital sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 216,927 shares — an estimated $2.81M sold.

SummitTX Capital first reported a position in DVAX in Q1 2025 and held it in 1 quarter. The position peaked at $2.81M in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • SummitTX Capital reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • SummitTX Capital sold 216,927 Dynavax Technologies shares in Q2 2025, an estimated $2.81M.
  • SummitTX Capital first reported a position in Dynavax Technologies in Q1 2025 and held it in 1 quarter.
  • SummitTX Capital's Dynavax Technologies position peaked at $2.81M in Q1 2025.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on SummitTX Capital's 13F filing for Q2 2025, filed 14 Aug 2025.